<html> <head> <meta http-equiv="Content-Type" content="text/html; charset=shift_jis"> <meta http-equiv="Content-Language" content="ja"> <meta name="GENERATOR" content="Microsoft FrontPage 4.0"> <meta name="ProgId" content="FrontPage.Editor.Document"> <title>Oncology Tools</title> <script type="text/javascript" src="/fsrscripts/triggerParams.js"></script> <script type="text/javascript" src="/fsrscripts/stdLauncher.js"></script> <script type="text/javascript">Poll();</script> </head> <body> <table border="0" cellPadding="0" cellSpacing="0" width="718"> <tr> <td align="left" width="718"><p align="center"><font color="#0080ff" face="ms sans serif, verdana, helvetica, arial" size="1">U.S. Food and Drug Administration</font><font face="ms sans serif, verdana, helvetica, arial" size="-2"><font color="#cc0000" face="arial, verdana" size="-1"> " </font> <font color="#0080ff">Center for Drug Evaluation and Research</font></font></p></td> </tr> </table> <DIV></DIV><div align="left"> <table border="0" cellPadding="0" cellSpacing="0" width="719"> <tr> <td align="middle" width="719"><IMG alt="Oncologytoolscouple.GIF(7450 bytes)" height=72 src="graphics/Oncologytoolscouple.GIF" width=476></td> </tr> </table> </div><div align="left"> <div align="center"> <center> <table border="0" cellpadding="0" cellspacing="4" width="687" height="506"> <tr> <td valign="bottom" colspan="3" width="677" height="140"><p align="center">&nbsp;</p> <p align="center">s|齎邩罷;S瑓罷@\0;S瑓罷U姟O繆鹓򔣜򠸖0Lv籰Bvn0_00n0臽1X茤0(Oncology Tools)</p> <p align="center">0</p></td> </tr> <tr> <td width="160" height="27"></td> <td width="20" height="27"></td> <td width="485" height="27"> <P><FONT > Japanese (Kanji viewer needed)./錯,g瀶Hr</FONT></P> <P><FONT> <A href="tour.htm"><STRONG>English<EM>o0S0S0𖐼0򬿴</EM></STRONG></A> <A href="French-tour.htm"><STRONG>French/francais</STRONG></A>&nbsp;&nbsp; <A href="German-tour.htm"><STRONG>German/Deutsch</STRONG></A>&nbsp;&nbsp; <A href="Dutch-tour.htm"><STRONG>Dutch/nederlands</STRONG></A>&nbsp;&nbsp; </tr> <tr> <td valign="top" width="160" height="327"><em>橆v</em> <p style="BACKGROUND-COLOR: #6600ff; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><A href="approved.htm"><font color="#ffffff">Approved Oncology Drugs <br> b崐瑓 </font></A></font></p> <p style="BACKGROUND-COLOR: #000099; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.accessdata.fda.gov/scripts/cder/onctools/disum.cfm"><font color="#ffffff">Disease Summaries <br> &nbsp;緐%R臽1X </font></a></font></p> <p style="BACKGROUND-COLOR: #6600ff; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.fda.gov/cder/cancer/consensusframe.htm"><font color="#ffffff">Regulatory Tools <br> &nbsp;誰0弶GR茤 </font></a></font></p> <p style="BACKGROUND-COLOR: #000080; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.fda.gov/cder/cancer/oncrefto.htm"><font color="#ffffff">Oncology Reference Tools <br> &nbsp;k vf[耂gq茤 </font></a></font></p> <p style="BACKGROUND-COLOR: #6600ff; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.fda.gov/oashi/cancer/cancer.html"><font color="#ffffff">Patient Liaison Program&nbsp; <br> &nbsp;U00翺n0臽1X </font></a></font></p> <p style="BACKGROUND-COLOR: #000080; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.fda.gov/cder/cancer/websitesframe.htm"><font color="#ffffff">Additional Resources <br> &nbsp;]0n0諲n0臽1X </font></a></font></p> <p style="BACKGROUND-COLOR: #6600ff; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><A href="home.htm"><font color="#ffffff">Oncology Tools Home<br> 󷀶0 </font></A></font></p> <p style="BACKGROUND-COLOR: #000080; BORDER-BOTTOM: #000080 2px solid; BORDER-LEFT: #000080 2px solid; BORDER-RIGHT: #000080 2px solid; BORDER-TOP: #000080 2px solid; COLOR: #ffffff; MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 3px; PADDING-RIGHT: 3px; TEXT-INDENT: 0px" align="center" ><font size="2"><a href="http://www.fda.gov/cder/"><font color="#ffffff">CDER Home</font></a><font color="#ffffff"><a href="http://www.fda.gov/cder/"><br> <u>00</u></a></font></font></p></td> <td width="20" height="327"></td> <td valign="top" width="485" height="327"> <hr size="3" color="#000080"> <p align="center"><b><font size="4">FDAh0b崐򈆸򶖆n09}薔</font></b><br> </p> <CENTER></CENTER> <P align=left style="LINE-HEIGHT: 150%"><b>s|齎邩罷;S瑓罷@\ (U.S. Food and Drug Administration; FDA)h0o0<br> <br> </b>s|齎邩罷;S瑓罷@\ (U.S. Food and Drug Administration; FDA)o0<a href="http://www.hhs.gov">Department of Health and Human Service</a>錯,gn0歋u碦蚉wk0鴙S_ k0^\Y00?e淾_jg0篘摃0誖irk0O(uY00龍罷n0弶6R0U姟O0L圖0~0Y00瑓dR0邩罷o00a000S罷0;SBv_jhV0+T~00~0Y0 <br> <b><br> FDAn0;Nj0t鮛h0w賀o0</b><br> <br> FDAo0誰媉k000歔Ö0_0d0n0鶺,gt鮛k000zvU\W0~0W0_00]00o0篘摃0誖irk0O(uY00龍罷o0+T gbRL0f奤000S0h00塠hQg0B00S0h00筊済L0B00S0h00h0D0F00n0g0Y00S000n0t鮛o0錘 Nn0S0h00L團0褃f[剉j0D}T~x0h0zvU\W0f0D0M0~0W0_00<br> <br> *gb崐龍罷k0Y00f鑱奮f殏0+T0 0鉽枆Y00_000塠hQ'`n0U姟O0L團00<br> 龍罷n0^⿲S1婏S0梍0_00k0衏鶴U00_0塠hQ'`h0 g筊'`k0Y00򹟖򠧲U姟OY00b崐閇鹓N z 0<br> 龍罷L0^⿲U00_0宊00塠hQ'`0檥殅剉k0繆鹓Y000<br> <br> FDAk0d0D0f00c0h0鍂0_0D0筫o0<a href="http://www.fda.gov/opacom/7history.html">FDAn0tk騍</a>0<a href="http://www.fda.gov/cder/about/history/default.htm">;S瑓罷U姟O繆鹓򔣜򠸖&nbsp; (CDER)n0tk騍</a>0<a href="http://www.fda.gov/cder/about/faq/default.htm">;S瑓罷U姟O繆鹓򔣜򠸖 (CDER)k00O0腫[0000陮OU</a>0<a href="http://www.fda.gov/opacom/hpview.html">FDAn0N,偱`1X</a>00*妼0f0O0`0U0D00<br> <br> <b>FDAn0)jP杗09h郻o0</b><br> <br> FDAn0)jP杘0藌誰钀昸0006R歔U00_0誰媉 (law)h00#惁?e淾n0L?e钀昸00c0f06R歔U00_0誰媉n0銐葢g0B00弶} (regulation)k0鶺e0D0f0D0~0Y00誰媉o0<a href="http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm">Food, Drug and Cosmetic Act</a>k00弶}o0<a href="http://www.access.gpo.gov/cgi-bin/cfrassemble.cgi?title=199821">Code of Federal Regulations</a>鑱奮f歬0Y00臽1X0銐葢0J屘[g0鑱奮f歬0:d00筫o0亯鑜顅g0Y0 k0 廲0f0D0~0Y00FDAn0򁹶0k0o000孾hQj0<a href="http://www.fda.gov/opacom/laws/lawtoc.htm">FDAk0Y00誰媉h0弶}n00򎒾</a>L0瞔 廢00f0D0~0Y00<br> <br> <b>f鑱奮f o0i0n00F0k0絜L圲000弶6RU000n0K0</b><br> <br> ;S瑓罷o00~0Z0gRk0誖ir焄欼{n0宊 篘摃k0塠hQk0昩Ng0M00K0i0F0K0n0f歐0j0O0f0o0j00~0[000]0n0宊k0;S瑓罷h0W0f0n0 g筊'`h00B00緐k0㘚W0f0筊済L0B00K0i0F0K0L0f歎00~0Y0~0Z0o0塠hQ'`h0昩N蠎n0zl歔0!kk0 g筊'`n0簒崐 0篘摃g0n0f殥0L團0_00k0o00Investigational New Drug Application (IND)0FDAk0衏鶴W0j0O0f0o0j00~0[000FDAh0絜-妌0+Pt訷酺O (Institutional Review Board; IRB)o0衏鶴U00_0鑱奮f;uL0S_g0B00K00+Pt NOUL楲0j0D0K00閇鹓W0j0O0f0o0D0Q0~0[000<a href="http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm">;S瑓罷n0IND衏鶴Kb</a>0<a href="http://www.fda.gov/cber/ind/ind.htm">uirf[剉籰Bv誰zOP[籰Bvﵠ񯡈00@埐m龍dRj0i0 n0IND衏鶴Kb</a>0<a href="http://www.fda.gov/oc/oha/IRB/toc.html">+Pt訷酺O (IRB)k0Y00N,偱`1X</a>o0]00^00n0򁹶򼓪耂gqW0f0O0`0U0D00<br> <br> INDk0衏鶴[000鴉^榢0o008^孨.z^榥0誖ir焄殘00j00MR鑱奮f毲0000鑱奮f殶[絜;uﱰ0򼘴000f0000昩N蠎h0昩N򎏘򋒨00n09h郻L0+T~00~0Y00梑L00dRn0F0a00簁0}迉剉蚉M00Y00梑L00dRn0篘SOk0R0f0昩NY00洊n0(u蠎Phase If歯0R轛昩N蠎 n0zl歔誰n0󤡐0򦾌00o0<a href="http://www.fda.gov/cder/cancer/docs/doseflow.pdf">S0a00</a>0T000O0`0U0D00<br> <br> <b>INDo0i0n00F0k0閇鹓U000K0</b><br> <br> FDAo0誰k0歔ôh0S00k0000INDn0譙Q0諷00030錯錘匭k0;S+^0瑓f[0襨'`f[0Sf[j0i000薸bU000򧂆0k00c0f0鑱奮f歯0;uh0󪫀򼘴000閇鹓W0~0Y00S0n0򧂆0o0衏鶴U00_0;uL0塠hQK0i0F0K0閇鹓W0~0Y00Y0j00a00珗軴w媙0_00k0塠hQ'`k0W0f0iRj0V{0鑜aL0絜U00f0D00K0i0F0K0閇鹓W0~0Y00鑱奮f歯0焄絜;uﱰ0򼘴00o0<b>塠hQ'`n09h郻</b>h0褃f[剉j0OUL榢0T{H0000媺紡0U姟O0銐恎L0iRk0j0U000K0 L0U姟OU00~0Y00INDn0閇鹓k0J0D0f0o0塠hQ'`L0誰剉9h郻n0B006RP橆vg0B000 g筊'`k0W0f0o0鑱奮f-Nbkj0i0誰媉k00c0f0弶歔U00_0ag鯪o0B00~0[000<br> <br> 鑱奮f殥0絜L圷00S0h001婏SW0_0h0D0F0S0h0o00^⿲01婏SW0_0h0D0F0S0h0h0o0puj00~0Y00誰媉o0^⿲L0崐颯U00f0D0j0D0瑓k0㘚W0f00檈褢0確蜸W0_00OY00S0h00亂X0f0D0~0Y00W0K0W00f毈卬0昩Nk0Y00粚(u00oR\O(u鶴⺳Bfn0;SBv粚k0W0f0o0珗k0藠BlY00S0h0L0g0M0~0Y00<br> <br> Oncology Toolsk0o0焄洊k0<a href="http://www.fda.gov/cder/cancer/oncrefto.htm">鑱奮f殥0L團0n0k0y_k0藌d0򰐮0</a>0Tk vn0򎒪0򋔴0n0_00n0􀇴0񇨔0󘊀񝍆􀎄򎐨򶚞򠭸 (performance status; P.S.)n0$R歔h0oR\O(u$R歔h0篘摃h0誖irx0n0昩N蠎n0姉{_j0篘摃n0臺亯8彶m蠎姉{_jL0 廲0f0D0~0Y00U00k0臽1XL0{0W0D04XTo0<a href="http://www.fda.gov/cder/cancer/regtools.htm">FDA閇鹓钀</a>k0#恆}W0f0O0`0U0D00<br> <br> <b>籰毈(investigational drugs)g0籰Bv0譙Q00k0o0i0F0Y00K0</b><br> <br> 籰毈(investigational drugs)o08^0b崐U00_0籰BvN,俴0 g筊'`L0簒藌U00_0籰Bv L0絜U00_0宊㙔0n0梄杒0崐ô4XTk0O(uU00~0Y00 g筊'`n0焄<奤00_0籰Bv誰n0j0D0񦚔n04XTk0o00Y0P0k0籰毈(investigational drugs)n0鑱奮f歬0U0𙑒耂燫U0[00S0h0o0S_g0B00h0H000~0Y00Oncology Toolsk0o0<A href="approved1.htm">籰毈(investigational drugs)</A><A href="approved1.htm">g0籰Bv0譙Q00_00n0Kb_M0</A>籰歺0n0耂燫j0i0 0 廲0f0D0~0Y00⺳(W2怢-Nn0梑L00dRn0鑱奮f歯0s0}o0Clinical Trial Listingsk0 廲0f0D0~0Y00<a href="http://cancertrials.nci.nih.gov/finding/index.html">齎藌L00xvz (National Cancer Institute; NCI)n0鑱奮f氷0򎒾</a>o0僞O0񣏾0W0f0D0~0Y0L0hQf0n02怢-Nn0鑱奮f殥0瞹W0f0D000Q0g0o0B00~0[000\0S000k00򎒾񇢄0U00_0f殥0FDAL0╟hYW0f0D000Q0g0o0B00~0[000<br> <br> <b>b崐~0g0n0Kb榦0</b><br> <br> 0W0f歎00_0;S瑓罷L00B00緐k0㘚W0f0塠hQk0昩Ng0M00W0K00 g筊g0B00h0H00k0硩0ASRj0򹟖0L0梍00_0j00p00]0n0P}済o0New Drug Application (NDA0b崐閇鹓3u藠 k0~0h0Ö00FDAk0衏鶴U00~0Y00uirf[剉龍罷0;SBv_jhVk0W0f00 T豬g0Y00;S+^0瑓f[0襨'`f[0Sf[j0i000薸bU000FDAn0򧂆0o0NDAn0譙Q0諷000mQ0g錘匭priority諲k0 g筊j0籰Bv誰k0ONW0D000W0O0o0蛻亯n0貧D0񦚔籰Bvk0㘚W0f0yrk0崐歔U000 0B00D0o0AS0g錘匭standard k0閇鹓Y00S0h0L0誰媉k00c0f0歔Ö0f0D0~0Y00閇鹓򧂆0o0qSz'`oR\O(u h0 g筊'`k0鶺e0M00b崐3u藠U00_0瑓dRk0^⿲n0b崐0NH00K0i0F0K0zl歔W0~0Y00<a href="http://www.fda.gov/cder/regulatory/applications/nda.htm">;S瑓罷n0NDAn0衏鶴n0誑筫</a>0<a href="http://www.fda.gov/cder/regulatory/applications/default.htm#h">b崐閇鹓N z</a>k0d0D0f0o0CDER;S瑓罷U姟O繆鹓򔣜򠸖 n0򁹶򼓪耂gqW0f0O0`0U0D00癳瑓n0zvU\k0Y00蟷靊o0<a href="http://www.fda.gov/cder/handbook/index.htm">CDER󒄼򿣊򬿴</a>0耂gqW0f0O0`0U0D00<br> <br> FDAo0願OU訷酺O (advisory committee)h0W0f0鍂000\暥[K00鉔h垊0坢粚鉜SO鉔h垈0燫00~0Y0L0 薸bU000訷酺Ok00瑓0龍罷n0b崐3u藠0崐ôK0&TzlY00K0FDAL0zl歔Y00_00k0臺亯j0㏑姃0Bl0~0Y00FDAn0󷀶􆓺00k0o0<a href="http://www.fda.gov/ohrms/dockets/ac/acmenu.htm">願OU訷酺On0N,倓vj0臽1X</a>L0 廲0f0D0~0Y00Oncology Toolsn0%Rn0󳻾0k0o0񦍾򣻴003u藠鴉豬_0梑k v瑓願OU訷酺O (Oncologic Drugs Advisory Committee; ODAC)n0圢歔h垊0<a href="http://www.fda.gov/cder/cancer/ODACframe.htm">p媼N2</a>j0i00+T0梑k vBv誰k0W0f0<a href="http://www.fda.gov/cder/cancer/consensusframe.htm">FDAL0NY00豬0j0婲</a>k0d0D0f0n0臽1XL0 廲0f0D0~0Y00<br> <br> <b>FDAk000b崐k0o0i0n00F0j0asTL0B00n0K0</b><br> <br> FDAk000b崐U00_0b崐U00j0K0c0_0h0D0F0S0h0o00瑓0龍罷陙SOk0㘚W0f0h0D0F00000B00񦚔k0㘚W0f0n0籰Bv誰h0W0f0^⿲W0_0D0h0D0F03u藠L0b崐U00_0h0K0b崐U00j0K0c0_0h0D0F0S0h00asTW0~0Y00b崐Bfk0o0S0n0i愜_緐0O(u(u蠎k0㘚W0f0^⿲n01婏SL0NH0000鹠豊鴉k0 廢00~0Y00FDAo0}90.z^榥0;S瑓罷0L00籰Bv(uk0崐颯W0f0D0~0Y00Oncology Toolsk0o0<A href="approved.htm">崐颯U00_0梑k v瑓</A>n0i愜_緐0鹠豊鴉0b崐閇鹓n0亯}j0i0L0 廲0f0D0~0Y00<br> <br> FDAL0NDA0b崐W0j0D004XT N妌00F0j0t1uk000~0Y00<br> <br>  g筊'`0塠hQ'`j0i03u藠W0f0D00匭筟0蠄豊Q00n0k0ASRj0<娻bL0򹟖0 L0j0D00<br> oR\O(uj0i0n00򎏄L01姽[膡騐0厤H0f0D000<br> FDAh0򎖐0򂇦龍瑓O>yj0i0n03u藠 L0i愜_緐0昩N蠎j0i000W0O0o0]000n0鹠豊鴉x0n0 弲Q筟k0W0f0 Tak0T怶0j0D00<br> <br> gRk03u藠W0_0婲i愜_緐0昩N誰j0i0 g0b崐U00j0K0c0_0梑k v瑓n0YO0L00峇3u藠﯐00n0龔燫03u藠婲榥0 Y鬴j0i0g0]0n0宊b崐U00f0D0~0Y00<br> <br> FDA0#惁?e淾0;S瑓罷n0焄洊n0O(uk0W0f0o0弶6R0W0f0J00~0[000i0n0崐颯瑓0;S+^n0翀蠎k0000鹠豊鴉k0 廢00f0D00匭筟i愜_莡0(u蠎 錘Yn0O(uL01奤00~0Y00i愜_YO(u (Off-label use)o0U愓lg0o0B00~0[000W0K0W00]0n0i愜_YO(uk0Y00򹟖0o0FDAk00c0f0閇鹓U00_00n0g0o0j0D0S0h00t銐W0f0D0j0O0f0o0j00~0[00龍瑓O>y0i愜_YO(uk0Y00僞JTo0g0M0~0[00 0<br> <br> 鹠豊鴉k0 廢00f0D0j0D0oR\O(u00oR\O(uk000eQb枓0亯W0_00{kW0_04XTk0o0J\Q0鶴0賀L0B00~0Y00<a href="http://www.fda.gov/cder/cancer/consensusframe.htm"> g砙婲a宯0J\鶴</a>k0W0f0o0S0a000T0O0`0U0D00</P> <P><strong><small>FDA/Center for Drug Evaluation and Research<br> Last Updated:&nbsp;<script language="javascript"> <!-- document.write(document.lastModified) //--> </script><br> Originator: OTCOM/DLIS<br> HTML by&nbsp; SH</small></strong></P> <P><STRONG><SMALL>Japanese Translation by Fumitaka Nagamura, MD<br> Reviewed by Ken Kobayashi, MD </SMALL></STRONG></P></FONT></FONT></FONT> </td> </tr></table> </div></CENTER></div> </body> </html>